Direct-to-consumer prescription drug advertising: Concerns and evidence on consumers' benefit

Journal of Consumer Marketing

Volumn 22, Issue 7, 2005, Pages 397-403

  Shin, Jaeun ^a   Moon, Sangho ^b  

^a Korea Development Institute   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Advertising; Consumers; Drugs; Medical prescriptions

Indexed keywords

EID: 28844480482     PISSN: 07363761     EISSN: None     Source Type: Journal    
DOI: 10.1108/07363760510631138     Document Type: Article

References (35)

1. Allison-Ottey, S.D., Ruffin, K. and Allison, K.B. (2002), "'To do no harm': survey of NMA physicians regarding perceptions on DTC advertisements", Journal of the National Medical Association, Vol. 94 No. 4, pp. 194-202.
2. American College of Physicians-American Society of Internal Medicine (1998), Direct-To-Consumer Advertising for Prescription Drugs 9, American College of Physicians-American Society of Internal Medicine, Philadelphia, PA.
3. American Pharmaceutical Association (1997), Navigating the Medication Marketplace: How Consumers Choose, American Pharmaceutical Association, Washington, DC.
4. Avorn, J. (2003), "Advertising and prescription drugs: promotion, education, and the public health", Health Affairs, pp. W3-104, Web Exclusive.
5. Avorn, J., Chen, M. and Hartley, R. (1988), "Scientific versus commercial sources of influence on the prescribing behavior of physicians", American Journal of Medicine, Vol. 73 No. 1, pp. 4-8.
6. Batchlor, E. and Laouri, M. (2003), "Pharmaceutical promotion, advertising, and consumers", Health Affairs, pp. W3-109, Web Exclusive.
7. Bell, R., Kravitz, R. and Wilkes, M. (1999), "Direct-to-consumer prescription drug advertising and the public", Journal of General Internal Medicine, Vol. 14 No. 11, pp. 651-7.
8. Bell, R., Wilkes, M. and Kravitz, R. (2000), "The educational value of consumer-targeted prescription drug print advertising", Journal of Family Practice, Vol. 49 No. 12, pp. 1092-8.
9. Bonifazi, W.L. (2002), "Hard sell: drug makers are spending billions on direct-to-consumer ads, but just how effective are the products?", Wall Street Journal, March 25.
10. Carlton, D.W. and Perloff, J.M. (2000), "Advertising and disclosure", Modern Industrial Organization, 3rd ed., Addison Wesley Longman, Reading, MA.
11. Cohen, E.P. (1988), "Direct-to-the-public advertisement of prescription drugs", New England Journal of Medicine, Vol. 318 No. 6, p. 373.
12. Conti, R., Dorosh, E., Epstein, A.M., Frank, R.G., Huskamp, H.A. and Rosenthal, M.B. (1999), "Prescription drug policy issues in California", report prepared for the California Health Care Foundation, April.
13. Dubois, R.W. (2003), "Pharmaceutical promotion: don't throw the baby out with the bathwater", Health Affairs, pp. W3-96, Web Exclusive.
14. Dubois, R.W., Batchlor, E. and Wade, S. (2002), "Geographic variation in the use of medications: is uniformity good news or bad?", Health Affairs, Vol. 21 No. 1, pp. 240-50.
15. Dubois, R.W., Alexander, C.M., Wade, S., Mosso, A., Markson, L., Lu, J.D., Nag, S. and Berger, M.L. (2002), "Growth in use of lipid lowering therapies: are we targeting the right patients?", American Journal of Managed Care, Vol. 8 No. 10, pp. 82-7.
16. Fintor, L. (2002), "Direct-to-consumer marketing: how has it faired?", Journal of the National Cancer Institute, Vol. 94 No. 5, pp. 329-31.
17. Hollon, M.F. (1999), "Direct-to-consumer marketing of prescription drugs: creating consumer demand", Journal of American Medical Association, Vol. 281 No. 4, pp. 382-4.
18. Jeffords, J.M. (2004), "Direct-to-consumer drug advertising: you get what you pay for", Health Affairs, pp. W4-253, Web Exclusive.
19. Kelly, P. (2004), "DTC advertising's benefits far outweigh its imperfections", Health Affairs, pp. W4-246 (web exclusive).
20. Kessler, D.A. and Pine, W.L. (1990), "The Federal Regulation of prescription drug advertising and promotion", Journal of the American Medical Association, Vol. 264 No. 18, pp. 2409-15.
21. Kravitz, R.L. (2000), "Direct-to-consumer advertising of prescription drugs", Western Journal of Medicine, Vol. 173 No. 4, pp. 221-2.
22. Lipsky, M.S. and Taylor, C.A. (1997), "The opinions and experiences of family physicians regarding direct-to-consumer advertising", Journal of Family Practice, Vol. 45 No. 6, pp. 495-9.
23. Morris, L.A., Brinberg, D., Klimberg, R., Rivera, C. and Millstein, L.G. (1986), "Miscomprehension rates of prescription drug advertisements", Journal of Current Issues and Research in Advertising, Vol. 9 Nos 1-2, pp. 93-117.
24. National Institute for Health Care Management (2002), "Prescription drug expenditure in 2001: another year of escalating costs", National Institute for Health Care Management, available at: www.nihcm.org/ spending2001.pdf/ (accessed January 6, 2003).
25. Petroshius, S.M., Titus, P.A. and Hatch, K.J. (1995), "Physician attitudes toward pharmaceutical drug advertising", Journal of Advertising Research, Vol. 35 No. 6, pp. 41-51.
26. Rosenthal, M.B., Berndt, E.R., Donohue, J.M., Frank, R.G. and Epstein, A.M. (2002), "Promotion of prescription drugs to consumers", New England Journal of Medicine, Vol. 346 No. 7, pp. 498-505.
27. T'Hoen, E. (1998), "Direct-to-consumer advertising: for better profits or for better health?", American Journal of Health-System Pharmacy, Vol. 55, pp. 594-7.
28. Tully, S. (1993), "The plots to keep drug prices high", Fortune, December 27, pp. 120-3.
29. US General Accounting Office (2002), Prescription Drugs: FDA Oversight of Direct-to-Consumer Advertising Has Limitations, Pub. No. GAO-03-177, US General Accounting Office, Washington DC.
30. Waxman, H.A. (2004), "Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?", Health Affairs, pp. W4-256 (web exclusive).
31. Weissman, J.S., Blumenthal, D., Silk, A.J., Newman, M., Zapert, K., Leitman, R. and Feibelmann, S. (2004), "Physicians report on patient encounters involving direct-to-consumer advertising", Health Affairs, pp. W4-219 (web exclusive).
32. Wilkes, M.S., Bell, R.A. and Kravitz, R.L. (2000), "Direct-to-consumer prescription drug advertising: trends, impact, and implications", Health Affairs, Vol. 19 No. 2, pp. 110-28.
33. Wolfe, S.M. (2002), "Direct-to-consumer advertising - education or emotion promotion?", New England Journal of Medicine, Vol. 346 No. 7, pp. 524-6.
34. Woloshin, S., Schwartz, L.M. and Welch, H.G. (2004), "The value of benefit data in direct-to-consumer drug ads", Health Affairs, pp. W4-234 (web exclusive).
35. Ziegler, M.G., Lew, P. and Singer, B.D. (1995), "The accuracy of drug information from pharmaceutical sales representatives", Journal of the American Medical Association, Vol. 273 No. 5, pp. 651-7.